Living With Frontotemporal Degeneration: Diagnostic Journey, Symptom Experiences, and Disease Impact
- PMID: 35943443
- PMCID: PMC10114256
- DOI: 10.1177/08919887221119976
Living With Frontotemporal Degeneration: Diagnostic Journey, Symptom Experiences, and Disease Impact
Abstract
Frontotemporal degeneration (FTD) is an umbrella term encompassing a range of rare neurodegenerative disorders that cause progressive declines in cognition, behavior, and personality. Hearing directly from individuals living with FTD and their care partners is critical in optimizing care, identifying meaningful clinical trial endpoints, and improving research recruitment and retention. The current paper presents a subset of data from the FTD Insights Survey, chronicling the diagnostic journey, symptoms, and the impact of FTD on distress, quality of life, and independence, in the mild to moderate stages of the disease. Survey respondents included 219 individuals diagnosed with FTD and 437 current care partners, representing a range of FTD diagnoses. Around half of survey respondents reported seeing three or more doctors before an FTD diagnosis was given, and a range of prior diagnoses were noted. Most frequently endorsed symptoms tended to be consistent with clinical characteristics of the specific diagnosis, though there was significant variability in symptoms reported within diagnostic categories as well as considerable overlap in symptoms between diagnostic categories. Cognitive and language symptoms of FTD were generally most distressing to the person diagnosed, and a loss of independence was endorsed as affecting quality of life. The distinct perspectives of diagnosed persons and care partners regarding disease impact differed notably for bvFTD/Pick's disease. Participating independently in a range of activities, within the home, outside the home, and with other people, were reported as challenging for people living with FTD, underscoring the degree to which the lives of these individuals are affected even at the mild and moderate stages of disease. Overall, by heeding the perspectives of those living with FTD, we can begin to design more meaningful research studies, provide better care, and develop therapies that improve quality of life.
Keywords: frontotemporal degeneration; frontotemporal dementia; lived experience; survey.
Conflict of interest statement
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: S. Cosentino: S.C. received funds from Association for Frontotemporal Degeneration to support her time for survey development, analysis, and manuscript planning.
Similar articles
-
Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.CNS Drugs. 2012 Oct 1;26(10):841-70. doi: 10.2165/11640070-000000000-00000. CNS Drugs. 2012. PMID: 22950490 Review.
-
Behavioral variant of frontotemporal dementia: Fundamental clinical issues associated with prediction of pathological bases.Neuropathology. 2016 Aug;36(4):388-404. doi: 10.1111/neup.12290. Epub 2016 Mar 11. Neuropathology. 2016. PMID: 26969837
-
Psychiatric symptoms in frontotemporal dementia: epidemiology, phenotypes, and differential diagnosis.Biol Psychiatry. 2015 Nov 15;78(10):684-92. doi: 10.1016/j.biopsych.2015.03.028. Epub 2015 Apr 8. Biol Psychiatry. 2015. PMID: 25958088 Review.
-
The Frontotemporal Dementia versus Primary Psychiatric Disorder (FTD versus PPD) Checklist: A Bedside Clinical Tool to Identify Behavioral Variant FTD in Patients with Late-Onset Behavioral Changes.J Alzheimers Dis. 2019;67(1):113-124. doi: 10.3233/JAD-180839. J Alzheimers Dis. 2019. PMID: 30584146
-
Frontotemporal Dementia - Current Concepts.Neurol India. 2021 Sep-Oct;69(5):1144-1152. doi: 10.4103/0028-3886.329593. Neurol India. 2021. PMID: 34747778 Review.
Cited by
-
Neuropsychiatric and behavioral symptom clusters in frontotemporal dementia.J Alzheimers Dis Rep. 2025 Mar 2;9:25424823251324391. doi: 10.1177/25424823251324391. eCollection 2025 Jan-Dec. J Alzheimers Dis Rep. 2025. PMID: 40034531 Free PMC article.
-
The Diagnostic Landscape of Behavioral Variant Frontotemporal Dementia.R I Med J (2013). 2025 May 1;108(5):17-22. R I Med J (2013). 2025. PMID: 40300053 Free PMC article. Review.
-
Frontotemporal Dementia Differential Diagnosis in Clinical Practice: A Single-Center Retrospective Review of Frontal Behavioral Referrals.Neurol Clin Pract. 2025 Feb;15(1):e200360. doi: 10.1212/CPJ.0000000000200360. Epub 2024 Oct 8. Neurol Clin Pract. 2025. PMID: 39399558 Free PMC article.
-
A new model to understand the complexity of inequalities in dementia.Int J Equity Health. 2024 Aug 14;23(1):160. doi: 10.1186/s12939-024-02245-w. Int J Equity Health. 2024. PMID: 39138491 Free PMC article.
-
Developing digital health technologies for frontotemporal degeneration.Alzheimers Dement. 2025 Apr;21(4):e70082. doi: 10.1002/alz.70082. Alzheimers Dement. 2025. PMID: 40285380 Free PMC article. Review.
References
-
- U.S. Food and Drug Administration . PDUFA V: Fiscal Years 2013 - 2017. FDAFDA; 2016. https://www.fda.gov/industry/prescription-drug-user-fee-amendments/pdufa....
-
- Benjamin K, Vernon MK, Patrick DL, Perfetto E, Nestler-Parr S, Burke L. Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials: An ISPOR COA Emerging Good Practices Task Force Report. Value Health. 2017;20(7):838-855. DOI: 10.1016/j.jval.2017.05.015. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical